For nearly a century, U.S. cosmetic regulation remained largely unchanged. That era officially ended with the passage of the Modernization of Cosmetics Regulation Act (MoCRA), and now, the FDA is racing to catch up.

In Episode 83 of the Orange Pill Podcast, we unpack five major regulatory developments that signal a fundamental shift in how cosmetics are tested, labeled, and enforced in the United States.

Drawing from recent FDA actions and the Fall 2024 Unified Agenda, this episode explores:

• The FDA’s long-awaited move to mandate asbestos testing in talc products
• Why the agency is using a broader mineral definition to future-proof safety
• How fragrance “trade secrets” are ending with allergen disclosure rules
• The delayed but historic push toward a formaldehyde ban in hair products
• How the 2025 administrative transition has triggered a widespread regulatory freeze impacting MoCRA timelines

We discuss what these shifts mean for brands, manufacturers, regulatory teams, and consumers, and why companies should already be preparing their quality systems, documentation, and compliance strategies.

This episode isn’t just about beauty. It’s about accountability, transparency, and the future of consumer protection.